YONIT ILYAGUYEV: Open Payments
NPI 1588107049 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$251 in 10 payments from 7 companies in 2025. Trend: 2023 $147 · 2024 $68 · 2025 $251
Food & beverage: $160Education: $91
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 1 | $91 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| Janssen Biotech, Inc. | 2 | $33 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $17 |
| Stemline Therapeutics Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: TAGRISSO, DARZALEX, CALQUENCE, NERLYNX, Orserdu, FRUZAQLA.
Industry payments across NY — which companies pay providers there.
